IP Library Granted Patent US 11,793,638
Granted Patent B2
US 11,793,638 · App. 16/896,858 · Granted Oct 24, 2023

Prosthetic valve with pivoting tissue anchor portions

Inventors: Ilia Hariton (Zichron Yaackov, IL); Boaz Harari (Ganey Tikva, IL)
Assignee: CARDIOVALVE LTD.
A61F2/2436A61F2/243A61F2/2409A61F2/2418A61F2/9517A61F2002/91575A61F2220/0016A61F2220/0025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,793,638
App. No.
16/896,858
Granted
Oct 24, 2023
Kind
B2
Abstract

Prosthetic heart valves and methods of use of prosthetic heart valves may be provided. In one implementation, a prosthetic heart valve may include an annular valve body and atrial anchors and ventricular anchors extending from the valve body. An atrial anchor may include a pivoting portion configured to extend in an upstream direction when the prosthetic heart valve is in a delivery configuration and in a downstream direction when the prosthetic heart valve is in a deployed-anchor configuration. A portion of a ventricular anchor may be configured to abut the annular valve body when the prosthetic heart valve is arranged in the delivery configuration.

Claims (23)

1. A prosthetic heart valve, comprising:

an annular valve body having a lumen extending between an upstream end of the annular valve body and a downstream end of the annular valve body;

a plurality of atrial anchors extending from the annular valve body, each atrial anchor having a proximal end secured to the annular valve body and a terminal end opposite from the proximal end; and

a plurality of ventricular anchors extending from the annular valve body, each ventricular anchor having a proximal end secured to the annular valve body and a terminal end opposite from the proximal end, wherein

the prosthetic heart valve is configured to be arranged in:

a delivery configuration in which the atrial anchors and ventricular anchors are configured to be contained at least partially within a delivery device and are arranged in respective delivery positions, and

a deployed-anchor configuration in which the atrial anchors and the ventricular anchors move radially outward from their respective delivery positions,

at least one atrial anchor includes a pivoting portion configured to extend from the annular valve body in an upstream direction when the prosthetic heart valve is in the delivery configuration and to extend from the annular valve body in a downstream direction when the prosthetic heart valve is in the deployed-anchor configuration, and

a first portion of at least one ventricular anchor is configured to abut the annular valve body when the prosthetic heart valve is in the delivery configuration and a second portion of the at least one ventricular anchor is configured to be situated upstream from at least part of the pivoting portion of the at least one atrial anchor when the prosthetic heart valve is in the deployed-anchor configuration.

2. The prosthetic heart valve of claim 1 , wherein the at least one atrial anchor and the at least one ventricular anchor are configured to extend from the annular valve body in an upstream direction parallel to a longitudinal axis of the annular valve body when the prosthetic heart valve is in the delivery configuration.

3. The prosthetic heart valve of claim 1 , wherein the first portion of the at least one ventricular anchor is arranged between the second portion and the proximal end of the at least one ventricular anchor.

4. The prosthetic heart valve of claim 1 , wherein the terminal end of the at least one atrial anchor is configured to be situated at a position upstream and radially-outward from the pivoting portion of the at least one atrial anchor, relative to a longitudinal axis of the annular valve body, when the prosthetic heart valve is in the deployed-anchor configuration.

5. The prosthetic heart valve of claim 1 , wherein the prosthetic heart valve is additionally configured to be arranged in a fully-expanded configuration, the annular valve body having a larger diameter when the prosthetic heart valve is in the fully-expanded configuration than when the prosthetic heart valve is in the delivery and deployed-anchor configurations.

6. The prosthetic heart valve of claim 5 , wherein the diameter of the annular valve body remains constant when the prosthetic heart valve transitions from the delivery configuration to the deployed-anchor configuration.

7. The prosthetic heart valve of claim 5 , wherein

the pivoting portion of the at least one atrial anchor is configured to extend from the annular valve body in a downstream direction when the prosthetic heart valve is in the fully-expanded configuration, and

the terminal end of the at least one atrial anchor is configured to be situated radially-outward from the pivoting portion of the at least one atrial anchor, relative to a longitudinal axis of the annular valve body, when the prosthetic heart valve is in the fully-expanded configuration.

8. The prosthetic heart valve of claim 1 , wherein the at least one atrial anchor includes an upstanding portion configured to extend in an upstream direction when the prosthetic heart valve is in the deployed-anchor configuration, the upstanding portion including the terminal end of the at least one atrial anchor.

9. The prosthetic heart valve of claim 1 , wherein the annular valve body comprises:

an annular outer frame; and

an inner frame positioned at least partially within the annular outer frame, wherein

the plurality of ventricular anchors extend from the annular outer frame and the plurality of atrial anchors extend from the inner frame.

10. The prosthetic heart valve of claim 9 , wherein the portion of the at least one ventricular anchor is configured to abut a portion of the inner frame when the prosthetic heart valve is in the delivery configuration.

Assignments (2)
SECURITY INTEREST Recorded Jun 10, 2021
From: CARDIOVALVE LTD.
To: BEST, LAWRENCE C.; OXO CAPITAL VALVE VENTURES LLC; PEREGRINE VC INVESTMENTS IV (IL) L.P.; PEREGRINE VC INVESTMENTS IV (US INVESTORS) L.P; PEREGRINE VC INVESTMENTS IV (OTHER INVESTORS) L.P.; NGN BIOMED OPPORTUNITY II, L.P.; IF A PE FUND II, LP; IF A PE FUND II US, LP
Reel/Frame 056539/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2020
From: HARITON, ILIA; HARARI, BOAZ
To: CARDIOVALVE LTD.
Reel/Frame 052906/0520 →
Continuity (6)
Continuation 15995725 · Jun 1, 2018
Continuation 15682789 · Aug 22, 2017
Continuation 15541783
Provisional Application 62112343 · Feb 5, 2015
Provisional Application 62560384 · Sep 19, 2017
Related Publication 20200297486A1 · Sep 24, 2020
Cited By (2)
US 12,396,851 US 12,611,305